This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Sandbox Reserved 1411

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (21:05, 12 February 2018) (edit) (undo)
 
(One intermediate revision not shown.)
Line 8: Line 8:
==Structure==
==Structure==
-
EPO is made up of a 166 amino acid chain. There are 4 <scene name='77/777731/Alpha_helices/1'>alpha helices</scene> shown in red which are arranged in a bundle. In the tertiary structure, there are two disulfide bonds, shown in yellow, which hold together this bundle. There are two active sites; <scene name='77/777731/Active_site_one/1'>site one</scene> responsible for binding to the receptor and <scene name='77/777731/Active_site_2/1'>site two</scene> causes dimerization.
+
EPO is made up of a 166 amino acid chain. There are 4 <scene name='77/777731/Alpha_helices/1'>alpha helices</scene> shown in red which are arranged in a bundle. In the tertiary structure, there are two disulfide bonds, shown in yellow, which hold together this bundle. There are two active sites for this protein. <scene name='77/777731/Active_site_one/1'>Site one</scene> is responsible for binding to the receptor on cell surfaces. <scene name='77/777731/Active_site_2/1'>Site two</scene> causes dimerization with other EPO subunits.
== Function ==
== Function ==
EPO receptors in the bone marrow triggers a signal transduction pathway that causes red blood cells to move into the blood stream.
EPO receptors in the bone marrow triggers a signal transduction pathway that causes red blood cells to move into the blood stream.
Line 17: Line 17:
==References==
==References==
https://www.rcsb.org/structure/1buy
https://www.rcsb.org/structure/1buy
 +
https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/anemia
https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/anemia
 +
https://www.ncbi.nlm.nih.gov/pubmed/9002951
https://www.ncbi.nlm.nih.gov/pubmed/9002951
 +
https://www.ncbi.nlm.nih.gov/pubmed/9783743
https://www.ncbi.nlm.nih.gov/pubmed/9783743

Current revision

This Sandbox is Reserved from January through July 31, 2018 for use in the course HLSC322: Principles of Genetics and Genomics taught by Genevieve Houston-Ludlam at the University of Maryland, College Park, USA. This reservation includes Sandbox Reserved 1311 through Sandbox Reserved 1430.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Erythropoietin

PDB ID 1BUY

Drag the structure with the mouse to rotate
Personal tools